MedPath

A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo (BYZJ) Formula for constipation in Parkinson's disease

Phase 1
Conditions
Parkinson' disease
Registration Number
ITMCTR2000003091
Lead Sponsor
Beijing Rehabilitation Hospital, Capital Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Diagnosed as idiopathic PD according to the 2015 MDS criteria;
2. Diagnosed as constipation according to Rome III diagnostic criteria;
3. Aged 30 to 80 years;
4. Hoehn and Yahr classification 1-4;
5. Sign informed consent and be able to insist on completing the entire treatment process.

Exclusion Criteria

1. Patients who do not take medication under the guidance of a professional doctor or cannot take medication regularly;
2. Patients with intestinal organic lesions such as intestinal polyps, intestinal tuberculosis, Crohn's disease, tumors and ulcers. etc;
3. Secondary constipation caused by uremia, muscular dystrophy, multiple sclerosis, hypothyroidism and other system diseases;
4. Patients with severe heart, brain, liver, kidney, blood system diseases, as well as mental disorders or dementia;
5. Higher serum creatinine, ALT or AST than twice the normal value;
6. According to the judgment of the researcher, patients who are unable to cooperate throughout the research due to drug abuse or poor adherence;
7. Participated in other studies in the past 2 weeks or is currently participating in other clinical trials; or has taken other traditional Chinese medicine preparations in the past 3 months;
8. Pregnant and lactating women.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
constipation severity instrument;
Secondary Outcome Measures
NameTimeMethod
PAC-QOL;PDSS;PFS-16;BSFS;NMSS;MDS-UPDRS;
© Copyright 2025. All Rights Reserved by MedPath